Flutter Entertainment (NYSE:FLUT) is one of the stocks with explosive growth potential. On February 26, Flutter Entertainment reported strong top-line momentum for Q4 2025, with group revenue increasing 25% and adjusted EBITDA rising 27%. The company’s US division, anchored by FanDuel, remained a primary growth engine, posting a 33% increase in revenue and 90% in adjusted EBITDA. This was supported by a 35% jump in sportsbook revenue and a 33% gain in iGaming. Internationally, revenue grew by 19%, supporte ...

Charles Thomas Munger, co-founder of Berkshire Hathaway alongside Warren Buffett, has built a following of his own among investors.The late billionaire left behind a treasure trove of tried and tested investing advice over the years and even Buffett (95), known as ‘The Oracle of Omaha’ for his impeccable investment decisions over the years, credits Munger for a key principle on avoiding major mistakes: “Really good investment opportunities aren't going to come along too often and won't last too long, so you ...

Samsara Inc. (NYSE:IOT) is one of the stocks with explosive growth potential. On February 26, Samsara announced the launch of its latest-generation Asset Tag and the all-new, ultra-compact Asset Tag XS, designed to track high-value equipment of all sizes. These ruggedized devices are engineered for extreme environments, with the standard Asset Tag offering a six-year battery life and the smaller XS model providing three years of power for handheld tools and specialized gear. To support these devices, Sam ...

IonQ Inc. (NYSE:IONQ) is one of the stocks with explosive growth potential. On February 25, IonQ reported a historic 2025, becoming the first quantum computing company to surpass $100 million in annual GAAP revenue. The company delivered $130 million for the full year, which was a 202% year-over-year increase, and significantly beat its own guidance. This growth was fueled by strong commercial traction, with 60% of revenue coming from commercial customers and 30% from international markets. A major shift ...

BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the stocks with explosive growth potential. On February 24, BridgeBio Pharma reported a transformative full-year 2025, marked by a surge in total revenue to $502.1 million. This was driven largely by the commercial success of its flagship product, Attruby. In Q4 alone, Attruby generated $146 million in net product revenue, reflecting a 35% increase over Q3. This growth was supported by 7,804 new patient starts and high levels of patient persistence. The compa ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the stocks with explosive growth potential. On February 23, Summit Therapeutics reported results for 2025 with a strong financial foundation, reporting ~$713.4 million in cash and no outstanding debt. While GAAP operating expenses for Q4 reached $225 million, this represented a decrease from the previous quarter. Conversely, non-GAAP operating expenses rose to $113.3 million as the company ramped up investment in its Harmony 3 and Harmony 7 clinical trials. ...

Chewy Inc. (NYSE:CHWY) is one of the stocks with explosive growth potential. On February 24, Chewy announced the appointment of Chris Deppe as its new Chief Financial Officer. Deppe, who joined the company in 2022, previously served as Vice President of Supply Chain & Operations Finance and most recently headed all Corporate and Commercial Finance functions. His selection followed a rigorous search process involving several external candidates, with CEO Sumit Singh citing Deppe’s deep institutional knowled ...

Equitable Holdings Inc. (NYSE:EQH) is one of the stocks with explosive growth potential. On February 5, Equitable Holdings reported full-year 2025 financial results highlighted by record assets under management and administration, which reached $1.1 trillion, a 10% increase year-over-year. The company generated $1.6 billion in organic cash during the year and expects this figure to rise to ~$1.8 billion in 2026. The firm’s growth was underscored by momentum in its Wealth Management segment, which achieve ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the stocks with explosive growth potential. On February 19, Madrigal Pharmaceuticals announced the earnings report for 2025, which was driven by the successful launch of Rezdiffra, the first approved treatment for MASH. Full-year net sales reached $958.4 million, with Q4 revenue alone hitting $321.1 million, more than tripling the previous year’s quarterly results. By the end of 2025, the patient base on Rezdiffra grew to over 36,250, up from ~29,500 in ...

So Rong Wei The numbers point to intense near-term tightness. Give us a little bit more guidance about what the data actually tells us. Right.So the price movements in today and yesterday both point to the fact that there is tightness in the market, as you mentioned. That's because the whole conflict in the Middle East region is still developing over the hours. As the hours go by, the market receives more news on what's happening in the Middle Eastern supply chain.So, like, for instance, yesterday when mark ...